|
⚲
|
| Keyboard |
| Duncan Barbara Gayle
✚
|
|
|---|---|
| CIK # | 0001353128 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001353128] | |
| 4 | [0001353128] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Ovid Therapeutics Inc OVID
Employee Stock Option (Right to Buy) · derivative
|
2026-02-26 | Grant | 65,000 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Stock Option (Right to Buy) · derivative
|
2025-06-20 | Grant | 41,200 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Restricted Stock Units · derivative
|
2025-06-20 | Grant | 29,600 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Restricted Stock Units · derivative
|
2025-06-20 | Option exercise | 29,600 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2025-06-20 | Option exercise | 29,600 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2025-05-01 | Grant | 4,165 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Option to Purchase Common Stock · derivative
|
2025-05-01 | Grant | 5,750 | $0.00 | |
|
Ovid Therapeutics Inc OVID
Stock Option (right to buy) · derivative
|
2025-02-20 | Grant | 45,000 | $0.00 | |
|
Ovid Therapeutics Inc OVID
Stock Option (Right to Buy) · derivative
|
2024-12-12 | Grant | 90,000 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Stock Option (Right to Buy) · derivative
|
2024-06-21 | Grant | 41,200 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Restricted Stock Units · derivative
|
2024-06-21 | Grant | 29,600 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2024-06-16 | Option exercise | 33,150 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Restricted Stock Units · derivative
|
2024-06-16 | Option exercise | 33,150 | $0.00 | |
|
Fusion Pharmaceuticals Inc FUSN
Stock Option (Right to Buy) · derivative
|
2024-06-04 | Disposed to issuer | 17,000 | ||
|
Fusion Pharmaceuticals Inc FUSN
Stock Option (Right to Buy) · derivative
|
2024-06-04 | Disposed to issuer | 30,000 | ||
|
Fusion Pharmaceuticals Inc FUSN
Stock Option (Right to Buy) · derivative
|
2024-06-04 | Disposed to issuer | 17,000 | ||
|
Fusion Pharmaceuticals Inc FUSN
Stock Option (Right to Buy) · derivative
|
2024-06-04 | Disposed to issuer | 17,000 | ||
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2024-04-25 | Grant | 6,501 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Option to Purchase Common Stock · derivative
|
2024-04-25 | Grant | 8,804 | $0.00 | |
|
Ovid Therapeutics Inc OVID
Stock Option (Right to Buy) · derivative
|
2024-02-22 | Grant | 30,000 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||